December 3, 2021 05:18 AM ESTUpdated 02:01 PM
Peer Review

Joseph Ar­ron march­es to the beat of his own drum at 23andMe; Ex-Voy­ager CFO joins Sek Kathire­san at Verve Ther­a­peu­tics

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Nicole DeFeudis

Editor

Joseph Ar­ron is some­times re­ferred to as the black sheep of his fam­i­ly. While every­one else is a pro­fes­sion­al mu­si­cian, he was al­ways more in­ter­est­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times